Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 161 citing articles:

Glioma targeted therapy: insight into future of molecular approaches
Keyang Yang, Zhijing Wu, Hao Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 486
Single-cell spatial immune landscapes of primary and metastatic brain tumours
Elham Karimi, Miranda W. Yu, Sarah M. Maritan, et al.
Nature (2023) Vol. 614, Iss. 7948, pp. 555-563
Open Access | Times Cited: 213
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
Víctor A. Arrieta, Crismita Dmello, Daniel J. McGrail, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 125
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
Yan Mei, Xiumei Wang, Ji Zhang, et al.
Nature Cancer (2023) Vol. 4, Iss. 9, pp. 1273-1291
Closed Access | Times Cited: 92
Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity
Yongbin Choi, Jake Lichterman, Laura Coughlin, et al.
Science Immunology (2023) Vol. 8, Iss. 81
Open Access | Times Cited: 67
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors
Michael Kilian, Ron Sheinin, Chin Leng Tan, et al.
Cancer Cell (2023) Vol. 41, Iss. 2, pp. 235-251.e9
Open Access | Times Cited: 66
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Mohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1134-1151.e10
Open Access | Times Cited: 66
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 62
CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma
Luuk van Hooren, Shanna M. Handgraaf, Daan J. Kloosterman, et al.
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 665-681
Open Access | Times Cited: 52
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target
Jiaxin Li, Jun Zhou, Huanhuan Huang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 48
Multiomics and spatial mapping characterizes human CD8 + T cell states in cancer
Stefan Naulaerts, Angeliki Datsi, Daniel Borràs, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 691
Open Access | Times Cited: 46
Macrophage-mediated myelin recycling fuels brain cancer malignancy
Daan J. Kloosterman, Johanna Erbani, Menno Boon, et al.
Cell (2024) Vol. 187, Iss. 19, pp. 5336-5356.e30
Open Access | Times Cited: 36
Glioblastoma vaccines: past, present, and opportunities
Zujian Xiong, Itay Raphael, Michael R. Olin, et al.
EBioMedicine (2024) Vol. 100, pp. 104963-104963
Open Access | Times Cited: 29
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu, Zhou Fei, Heba Ali, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1354-1375
Open Access | Times Cited: 22
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
Justin F. Gainor, Manish R. Patel, Jeffrey S. Weber, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2209-2223
Closed Access | Times Cited: 17
Dendritic cell maturation in cancer
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Unraveling UPR-Mediated Intercellular Crosstalk: Implications for Immunotherapy Resistance Mechanisms
Lu Si, Qimin Zhou, Rongjie Zhao, et al.
Cancer Letters (2025), pp. 217613-217613
Closed Access | Times Cited: 2
Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy
Kirsten A. White, Kate Connor, Maxime Meylan, et al.
Annals of Oncology (2022) Vol. 34, Iss. 3, pp. 300-314
Open Access | Times Cited: 63
Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer
Qiaoqi Chen, Liang Zhang, Lin Li, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 62
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
Daniel Kreatsoulas, Chelsea Bolyard, Bill X. Wu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 49
Glioblastoma Microenvironment and Cellular Interactions
Carmen Crivii, Adina Bianca Boşca, Carmen Stanca Melincovici, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1092-1092
Open Access | Times Cited: 45
From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
Brittany Dewdney, Misty R. Jenkins, Sarah A. Best, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 38
Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
Frank Eckerdt, Leonidas C. Platanias
Cancers (2023) Vol. 15, Iss. 13, pp. 3458-3458
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top